Keratitis Sicca (Dry Eye) - Causes, Treatment & When to See a Doctor

```html

What is Keratitis Sicca (Dry Eye)?

Keratitis sicca, more commonly called dry eye disease (DED), is a chronic, often multifactorial condition in which the eye does not produce enough tears, or the tears evaporate too quickly, leading to an unstable tear film. The resulting deficiency harms the surface of the eye (the cornea and conjunctiva) and can cause discomfort, visual disturbance, and an increased risk of eye infections.

The term “keratitis” refers to inflammation of the cornea, and “sicca” (Latin for “dry”) highlights the underlying tear deficiency. While occasional dryness after long screen time is normal, keratitis sicca is a persistent problem that usually requires medical evaluation and ongoing management.

Common Causes

Dry eye typically results from an imbalance between the aqueous, lipid, and mucin components of the tear film. Below are the most frequently encountered contributors:

• Age‑related decline in tear production – tear‑producing glands become less active after age 50.
• Meibomian gland dysfunction (MGD) – blockage or altered secretion of the oily layer leads to rapid tear evaporation.
• Autoimmune diseases – Sjögren’s syndrome, rheumatoid arthritis, lupus, and thyroid eye disease reduce tear output.
• Medications – antihistamines, decongestants, antidepressants, antihypertensives, and isotretinoin are known to decrease tear secretion.
• Environmental factors – low humidity, wind, air‑conditioned or heated rooms, and smoke accelerate tear evaporation.
• Contact lens wear – lenses can disrupt the tear film and cause mechanical irritation.
• Refractive surgery – LASIK or PRK may temporarily affect corneal nerves that stimulate tearing.
• Blepharitis – inflammation of the eyelid margin interferes with normal tear spreading.
• Systemic conditions – diabetes, vitamin A deficiency, and neuropathic disorders can affect lacrimal gland function.
• Digital device overuse – reduced blink rate during prolonged screen time leads to tear film instability.

Associated Symptoms

Patients with keratitis sicca often report a constellation of ocular complaints. Commonly reported symptoms include:

• Burning, stinging, or gritty sensation (“as if sand is in the eye”)
• Foreign‑body feeling
• Redness of the conjunctiva
• Excessive tearing (reflex tearing caused by irritation)
• Blurred vision that improves with blinking
• Photophobia (light sensitivity)
• Eye fatigue, especially after reading or computer work
• Difficulty wearing contact lenses
• Sticky or mucous discharge, especially upon waking

When to See a Doctor

Dry eye is often manageable with over‑the‑counter lubricants, but certain signs warrant prompt professional evaluation:

• Symptoms persisting >3 months despite regular artificial‑tear use.
• Severe discomfort, constant burning, or pain that interferes with daily activities.
• Frequent episodes of eye redness or swelling.
• Sudden change in vision, especially persistent blurriness.
• History of autoimmune disease, recent eye surgery, or use of systemic medications known to affect tear production.
• Repeated infections (conjunctivitis, keratitis) or corneal ulcers.

Early evaluation can prevent complications such as corneal scarring, ulceration, or permanent vision loss.

Diagnosis

Eye care professionals use a combination of patient history, clinical examination, and specialized tests to confirm keratitis sicca and gauge its severity.

History & Physical Exam

• Detailed symptom questionnaire (frequency, triggers, medication use).
• Assessment of eyelid position, blink rate, and presence of blepharitis.
• Slit‑lamp biomicroscopy to examine the cornea, conjunctiva, and tear film quality.

Objective Tests

• Schirmer test – strips of filter paper placed under the lower eyelid measure aqueous tear production (≤5 mm in 5 minutes suggests aqueous deficiency).
• Tear Break‑Up Time (TBUT) – fluorescein dye is applied; the time until the first dry spot appears is recorded. A TBUT <10 seconds indicates tear film instability.
• Ocular Surface Staining – fluorescein, lissamine green, or rose bengal highlight damaged epithelial cells.
• Meibomian Gland Evaluation – expression of glands and assessment of oil quality.
• Osmolarity testing – elevated tear osmolarity (>308 mOsm/L) is a hallmark of dry eye.
• Inflammatory markers – impression cytology or tear cytokine analysis (used mainly in research settings).

Treatment Options

Treatment is individualized based on the underlying cause, severity, and patient lifestyle. The goal is to restore a stable tear film, reduce inflammation, and protect the ocular surface.

Medical (Prescription) Therapies

• Topical cyclosporine A (Restasis®) or lifitegrast (Xiidra®) – immunomodulators that increase tear production and reduce ocular surface inflammation.
• Short courses of topical corticosteroids – for acute inflammatory flares, under close supervision.
• Prescription lubricating drops or gels – hyaluronic acid, carboxymethylcellulose, or lipid‑containing formulations for severe dryness.
• Punctal plugs – silicone or collagen plugs inserted into tear drainage ducts to retain tears longer.
• Oral tetracycline derivatives (doxycycline) or macrolides (azithromycin) – for meibomian gland dysfunction; they reduce inflammation and improve oil secretion.
• Autologous serum eye drops – used in refractory cases; contain growth factors that promote epithelial healing.

Home & Lifestyle Measures

• Artificial tears – preservative‑free drops used 4–6 times daily; for lipid deficiency, choose drops containing oily emulsions.
• Warm compresses & lid hygiene – 5‑10 minutes of a warm, moist cloth followed by gentle lid scrubs (e.g., diluted baby shampoo) to unblock meibomian glands.
• Environmental adjustments – use a humidifier, avoid direct drafts, and take frequent breaks during screen use (20‑20‑20 rule).
• Omega‑3 fatty acid supplementation – 1–2 g/day of EPA/DHA has been shown to improve meibomian gland function (supported by several RCTs).
• Protective eyewear – wrap‑around glasses in windy or dry conditions.
• Hydration & diet – adequate water intake and a diet rich in antioxidants (vitamins A, C, E) support ocular surface health.

Procedural Options

• Thermal pulsation (LipiFlow®) – applies controlled heat and pressure to the eyelids to melt and express obstructed meibum.
• Intense pulsed light (IPL) – reduces inflammation of the eyelid margin and improves gland function.
• Cryotherapy or laser therapy – for chronic punctal occlusion when plugs are ineffective.

Prevention Tips

While some risk factors (age, autoimmune disease) cannot be changed, many everyday habits can lower the likelihood of developing or worsening dry eye:

• Follow the 20‑20‑20 rule: every 20 minutes, look at something 20 feet away for 20 seconds to restore a normal blink rate.
• Stay hydrated – aim for 8 glasses of water a day.
• Limit exposure to smoke, wind, and air‑conditioning vents directly aimed at the face.
• Take regular “blink breaks” when wearing contact lenses or using digital devices.
• Choose preservative‑free artificial tears if you need frequent dosing.
• Maintain eyelid hygiene, especially if you have blepharitis or rosacea.
• Discuss medication side effects with your physician; alternative drugs may be available.
• Consider omega‑3 supplementation after consulting your healthcare provider.

Emergency Warning Signs

Key Take‑aways

Keratitis sicca is a common but often under‑recognized condition that can significantly affect quality of life. Understanding its causes, recognizing early symptoms, and seeking timely care are essential steps in preserving ocular health. Most patients achieve relief with a combination of lifestyle modifications, lubricating eye drops, and, when needed, prescription therapies. When warning signs appear—especially rapid vision loss or severe pain—prompt evaluation in an emergency setting is critical.

For further reading and evidence‑based guidelines, consult reputable sources such as the Mayo Clinic, the CDC, the NIH, and the Cleveland Clinic.

```